Home › Funds › Two Sigma Investments › TIL
Two Sigma Investments position in TIL
INSTIL BIO INC · Health Care
Latest position (Q2 2024)23.79K sh
Reported value held$244.80K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 121.81K | $563.00K | New |
| Q3 2022 | 23.14K | $112.00K | Reduce |
| Q4 2022 | 1.18M | $741.02K | Add |
| Q1 2023 | 1.16M | $763.64K | Reduce |
| Q2 2023 | 1.24M | $682.75K | Add |
| Q3 2023 | 1.06M | $455.07K | Reduce |
| Q4 2023 | 50.80K | $387.10K | Reduce |
| Q1 2024 | 44.40K | $479.52K | Reduce |
| Q2 2024 | 23.79K | $244.80K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TIL
- Vanguard Group 191.06K sh · $2.10M · Q4 2025
- UBS Group AG 177.42K sh · $1.36M · Q2 2026
- Millennium Management 134.57K sh · $1.03M · Q2 2026
- BlackRock Inc 55.50K sh · $426.83K · Q2 2026
- Renaissance Technologies 50.30K sh · $386.81K · Q2 2026
- Geode Capital Management 42.23K sh · $324.92K · Q2 2026
- Citadel Advisors 30.64K sh · $235.61K · Q2 2026
- Morgan Stanley 11.93K sh · $91.77K · Q2 2026
- Citigroup Inc 88 sh · $677 · Q2 2026